C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma.
Noguchi G, Nakaigawa N, Umemoto S, Kobayashi K, Shibata Y, Tsutsumi S, Yasui M, Ohtake S, Suzuki T, Osaka K, Muraoka K, Hasumi H, Kondo K, Igarashi Y, Sasada T, Kishida T, Yao M.
Noguchi G, et al. Among authors: nakaigawa n.
Cancer Chemother Pharmacol. 2020 Jul;86(1):75-85. doi: 10.1007/s00280-020-04088-y. Epub 2020 Jun 14.
Cancer Chemother Pharmacol. 2020.
PMID: 32537714